About Us
APTYS is a privately-held CRO spin-off of the University of Auvergne based in Clermont-Ferrand, France. Funded in 2002, the company acquired patents rights on pharmaceutical technologies from the University. APTYS’ business model is based on contract service. The sales turnover is invested on internal research programs that are feeding our technological portfolio.
